Search Results

Recovering From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

• Authors : Martin-Pozo MD; Williams EA ...

Subjects: Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/psychology ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/complications ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/rehabilitation

• Source: JAMA dermatology [JAMA Dermatol] 2026 Jan 01; Vol. 162 (1), pp. 24-30.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print

Record details

Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis: age-stratified insights from the FAERS database.

• Authors : Bayram-Ozgur D; Acibadem Mehmet Ali Aydinlar University Faculty of Pharmacy, Department of Pharmacology, Istanbul, Türkiye.; Colak O

Subjects: Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/epidemiology ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/etiology ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data

• Source: Jornal de pediatria [J Pediatr (Rio J)] 2025 Nov-Dec; Vol. 101 (6), pp. 101455. Date of Electronic Publication: 2025 Oct 23.Publisher: Elsevier Editora Ltd Country of Publication: Brazil NLM ID: 2985188R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Emerging causes of anticancer therapies-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: evidence from disproportionality analysis of the FDA adverse event reporting system.

• Authors : Liu W; Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

Subjects: Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/etiology ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/epidemiology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects

• Source: Frontiers in immunology [Front Immunol] 2025 Aug 27; Vol. 16, pp. 1646038. Date of Electronic Publication: 2025 Aug 27 (Print Publication: 2025).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Association of antibiotics with Stevens-Johnson syndrome and toxic epidermal necrolysis: A real-world pharmacovigilance study.

• Authors : Yan X; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.; Ma J

Subjects: Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/etiology ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/epidemiology ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/adverse effects

• Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2025 Aug; Vol. 66 (2), pp. 107524. Date of Electronic Publication: 2025 Apr 25.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Recommitting to Housing and Health Care Justice After City of Grants Pass v Johnson.

• Authors : Habib, Anand R.; Stella, Sarah A.; Farkouh, Elizabeth K.

• Source: American Journal of Public Health. Jan2025, Vol. 115 Issue 1, p18-22. 5p.

Record details

Johnson & Johnson CEO: America's innovation advantage starts with health.

• Authors : Duato, Joaquin (AUTHOR)

Subjects: *CORPORATE investments; BIOPHARMACEUTICS; ARTIFICIAL intelligence in medicineUNITED StatesJOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JNJ

• Source: Fortune.com. 5/10/2026, pN.PAG-N.PAG. 1p.

Record details

Improving Recruitment Through Social Media and Web-Based Advertising to Evaluate the Genetic Risk and Long-Term Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Community-Based Survey.

• Authors : Williams EA; Center for Drug Safety and Immunology, Vanderbilt University Medical Center, 2611 West End Avenue, STE 210, Nashville, TN, United States, 1 615-322-9174.; Martin-Pozo MD

Subjects: Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/genetics ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/complications ; Social Media*

• Source: Journal of medical Internet research [J Med Internet Res] 2025 May 07; Vol. 27, pp. e63712. Date of Electronic Publication: 2025 May 07.Publisher: JMIR Publications Country of Publication: Canada NLM ID: 100959882 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

FOURTH AMENDMENT — CANINE SNIFFS — FOURTH CIRCUIT HOLDS THAT A CANINE SNIFF AT AN APARTMENT FRONT DOOR IS NOT A "SEARCH." — United States v. Johnson, 148 F.4th 287 (4th Cir. 2025).

• Source: Harvard Law Review. Mar2026, Vol. 139 Issue 5, p1240-1248. 9p.

Record details

The Outcomes of SJS/TEN: A Nationwide Analysis.

• Authors : Murphy TJ; Department of Surgery, Vanderbilt University Medical Center, 1310 24th Avenue South, Nashville, TN 37212, United States.; Critical Illness, Brain dysfunction, and Survivorship (CIBS) Center, Center for Health Services Research, Vanderbilt University Medical Center, 2525 West End Avenue, Nashville, TN 37212, United States.

Subjects: Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/therapy ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/mortality ; Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/Stevens-Johnson Syndrome*/epidemiology

• Source: Journal of burn care & research : official publication of the American Burn Association [J Burn Care Res] 2026 May 05; Vol. 47 (3), pp. 723-729.Publisher: Oxford University Press Country of Publication: England NLM ID: 101262774 Publication Model: Print Cited Medium: Internet ISSN:

Record details

MarketLine Company Profile: Johnson & Johnson.

Subjects: *PHARMACEUTICAL industry; *MEDICAL equipment industryUNITED StatesJOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JNJ

• Source: Johnson & Johnson MarketLine Company Profile. 4/24/2026, p1-70. 70p.

Record details